Say Hello!
Don’t be shy.

 
0333 323 1843
 

[email protected]

 

BioCity Group HQ:
Pennyfoot Street
Nottingham
NG1 1GF

News

Nottingham UK – 11 October 2019. BioCity, the pioneering life science incubator and business collective opened its doors to one hundred young women from local schools on Tuesday 08 October 2019, to celebrate the tenth annual Ada Lovelace Day. The event, co-created and supported by BioCity, Ignite!,...

BioCity, Nottingham based Selentus Science Ltd is pleased to report that its partner CuraMedical BV (the Netherlands) has obtained regulatory approval for TenaTac® in the European Union. TenaTac® is an absorbable haemostat with improved tissue adhesion and is indicated for intra-operative surgical bleeding. The product...

We are excited to announce the collaboration with 3D Biotechnology Solutions (3DBS), the leading 3D bioprinting and electrospinning technologies manufacturer in Brazil. This collaboration is part of Biogelx international growth strategy program and aims to target public and private research institutes, universities and research consortiums in...

Nottingham based marketing and PR agency, V Formation, has launched a new ‘12 months of giving’ campaign, to raise funds for a different local charity for each month over the coming year. The ‘V Giving’ fundraising activities will include hosting cake sales, collecting donations, volunteering time...

BioCity, the pioneering life science incubator and business collective is set to open its doors to one hundred young women from local schools on Tuesday 08 October 2019. BioCity will be joined by Rolls Royce, The British Army, Twycross Zoo, Boots UK, Sygnature Discovery, XenoGesis and...

Upperton Pharma Solutions, a UK-based contract development and manufacturing organisation (CDMO) has significantly increased its tablet manufacturing capabilities following a strategic investment in a new state-of the-art tablet press. This investment will enhance the company’s development and manufacturing capabilities whilst strengthening their ability to support...

MediCity, Nottingham based regenerative medicine company has secured a £1.4m investment to fund clinical trials on its new cutting-edge treatment for dry eye disease. The funding for NuVision Biotherapies Ltd comes in part from the MEIF Proof of Concept & Early Stage Fund, which is managed...

Cheshire, UK - 03 September 2019   BioCity, the pioneering life science incubator and business collective has today announced investment in Maxwellia. The world’s first prescription (Rx) to Over the Counter (OTC) switch incubator, Maxwellia’s novel approach converts prescription drugs into versions that can be purchased without prescription...